Bank of America
NRXP icon

Bank of America’s NRX Pharmaceuticals NRXP Stock Holding History

Bank of America’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,239
Closed -$8.78K – 6498
2025
Q4 		$8.78K Sell
3,239
-161
-5% -$432 ﹤0.01% 6185
2025
Q3 		$11.2K Sell
3,400
-124
-4% -$355 ﹤0.01% 7182
2025
Q2 		$11.5K Buy
3,524
+181
+5% +$454 ﹤0.01% 7162
2025
Q1 		$6.85K Buy
3,343
+45
+1% +$127 ﹤0.01% 7178
2024
Q4 		$7.25K Buy
3,298
+8
+0.2% +$11 ﹤0.01% 7038
2024
Q3 		$5.56K Hold
3,290
– – ﹤0.01% 6989
2024
Q2 		$8.03K Buy
+3,290
New +$11.7K ﹤0.01% 6927
2024
Q1 		– Sell
-7
Closed -$34 – 8048
2023
Q4 		$34 Buy
+7
New +$23 ﹤0.01% 7569
2023
Q3 		– Sell
-3,000
Closed -$14.5K – 7885
2023
Q2 		$14.5K Hold
3,000
– – ﹤0.01% 6781
2023
Q1 		$19.8K Sell
3,000
-581
-16% -$5.89K ﹤0.01% 6758
2022
Q4 		$39.7K Buy
3,581
+3,548
+10,752% +$35.7K ﹤0.01% 6551
2022
Q3 		$0 Buy
33
+1
+3% +$7 ﹤0.01% 8073
2022
Q2 		$0 Sell
32
-117
-79% -$1.54K ﹤0.01% 8261
2022
Q1 		$3K Sell
149
-288
-66% -$9.37K ﹤0.01% 7985
2021
Q4 		$21K Sell
437
-1,499
-77% -$108K ﹤0.01% 7505
2021
Q3 		$179K Buy
+1,936
New +$252K ﹤0.01% 6374

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Bank of America's NRXP Position: Q1 2026 in Review

Bank of America sold out of NRX Pharmaceuticals (NRXP) in Q1 2026, closing a stake of 3,239 shares — an estimated $8.78K sold.

Bank of America first reported a position in NRXP in Q3 2021 and held it in 16 quarters. The position peaked at $179K in Q3 2021. 33 funds tracked by Wall St. Rank hold NRXP as of Q1 2026.

  • Bank of America reported no remaining NRX Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 3,239 NRX Pharmaceuticals shares in Q1 2026, an estimated $8.78K.
  • Bank of America first reported a position in NRX Pharmaceuticals in Q3 2021 and held it in 16 quarters.
  • Bank of America's NRX Pharmaceuticals position peaked at $179K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.